Drug name - Symbicort

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7759328 ASTRAZENECA Composition for inhalation Jan, 2023

(3 months from now)

US8575137 ASTRAZENECA Composition for inhalation Jan, 2023

(3 months from now)

US10166247 ASTRAZENECA Composition for inhalation Jan, 2023

(3 months from now)

US8143239 ASTRAZENECA Composition for inhalation Jan, 2023

(3 months from now)

US10166247

(Pediatric)

ASTRAZENECA Composition for inhalation Jul, 2023

(9 months from now)

US7759328

(Pediatric)

ASTRAZENECA Composition for inhalation Jul, 2023

(9 months from now)

US8143239

(Pediatric)

ASTRAZENECA Composition for inhalation Jul, 2023

(9 months from now)

US8575137

(Pediatric)

ASTRAZENECA Composition for inhalation Jul, 2023

(9 months from now)

US8875699 ASTRAZENECA Inhaler cap strap Nov, 2024

(2 years from now)

US8875699

(Pediatric)

ASTRAZENECA Inhaler cap strap May, 2025

(2 years from now)

US7587988 ASTRAZENECA Inhaler device counter Apr, 2026

(3 years from now)

US7587988

(Pediatric)

ASTRAZENECA Inhaler device counter Oct, 2026

(4 years from now)

US8387615 ASTRAZENECA Inhaler cap strap Mar, 2027

(4 years from now)

US8387615

(Pediatric)

ASTRAZENECA Inhaler cap strap Sep, 2027

(4 years from now)

US8528545 ASTRAZENECA Inhaler device that reduces the risk for miscounting a dosage Oct, 2028

(6 years from now)

US8616196 ASTRAZENECA Inhalation device and a method for assembling said inhalation device Apr, 2029

(6 years from now)

US8528545

(Pediatric)

ASTRAZENECA Inhaler device that reduces the risk for miscounting a dosage Apr, 2029

(6 years from now)

US8616196

(Pediatric)

ASTRAZENECA Inhalation device and a method for assembling said inhalation device Oct, 2029

(7 years from now)

Drugs and Companies using BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE ingredient

Treatment: Use for the treatment of asthma in patients 6 years of age and older; use for reducing exacerbations of chronic obstructive pulmonary disease; use for maintenance treatment of chronic obstructive pulmonary disease; Use for reducing exacerbations of chronic obstructive pulmonary disease; use for maintenance treatment of chronic obstructive pulmonary disease; use for the treatment of asthma in patients 6 years of age and older; Use for the treatment of asthma in patients 6 years of age and older; use for maintenance treatment of chronic obstructive pulmonary disease; use for reducing exacerbations of chronic obstructive pulmonary disease; Use for reducing exacerbations of chronic obstructive pulmonary disease; use for the treatment of asthma in patients 6 years of age and older; use for maintenance treatment of chronic obstructive pulmonary disease

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
0.08MG/INH;0.0045MG/INH AEROSOL, METERED;INHALATION Prescription
0.16MG/INH;0.0045MG/INH AEROSOL, METERED;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.